Novartis comments on $490m cell-culture vaccine contract
![Novartis comments on $490m cell-culture vaccine contract](/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_small/3/5/2/7/277253-4-eng-GB/Novartis-comments-on-490m-cell-culture-vaccine-contract.gif)
Late last week the US Department of Health and Human Services (HHS) awarded Novartis a $490m contract to continue work on its cell-culture influenza vaccine plant in Holly Springs, North Carolina, US. in-PharmaTechnologist spoke with Novartis spokesman Matt Stober about the new plant.